BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 27065319)

  • 1. α-Actinin-4 induces the epithelial-to-mesenchymal transition and tumorigenesis via regulation of Snail expression and β-catenin stabilization in cervical cancer.
    An HT; Yoo S; Ko J
    Oncogene; 2016 Nov; 35(45):5893-5904. PubMed ID: 27065319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma.
    Zhang ZQ; Chen J; Huang WQ; Ning D; Liu QM; Wang C; Zhang L; Ren L; Chu L; Liang HF; Fan HN; Zhang BX; Chen XP
    Mol Oncol; 2019 Apr; 13(4):792-810. PubMed ID: 30556279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NHERF1 inhibits beta-catenin-mediated proliferation of cervical cancer cells through suppression of alpha-actinin-4 expression.
    Wang Q; Qin Q; Song R; Zhao C; Liu H; Yang Y; Gu S; Zhou D; He J
    Cell Death Dis; 2018 Jun; 9(6):668. PubMed ID: 29867145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of ACTN4 in Tumorigenesis, Metastasis, and EMT.
    Tentler D; Lomert E; Novitskaya K; Barlev NA
    Cells; 2019 Nov; 8(11):. PubMed ID: 31766144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Actinin-4 regulates cancer stem cell properties and chemoresistance in cervical cancer.
    Jung J; Kim S; An HT; Ko J
    Carcinogenesis; 2020 Jul; 41(7):940-949. PubMed ID: 31584624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIP13 exerts a cancer-promoting role in cervical cancer by enhancing Wnt/β-catenin signaling via ACTN4.
    Liu X; Shen X; Zhang J
    Environ Toxicol; 2021 Sep; 36(9):1829-1840. PubMed ID: 34061428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slug inhibits the proliferation and tumor formation of human cervical cancer cells by up-regulating the p21/p27 proteins and down-regulating the activity of the Wnt/β-catenin signaling pathway via the trans-suppression Akt1/p-Akt1 expression.
    Cui N; Yang WT; Zheng PS
    Oncotarget; 2016 May; 7(18):26152-67. PubMed ID: 27036045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Klotho inhibits the capacity of cell migration and invasion in cervical cancer.
    Chang B; Kim J; Jeong D; Jeong Y; Jeon S; Jung SI; Yang Y; Kim KI; Lim JS; Kim C; Lee MS
    Oncol Rep; 2012 Sep; 28(3):1022-8. PubMed ID: 22710352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHN1 promotes epithelial-mesenchymal transition via the Akt/GSK-3β/Snail pathway in cervical carcinoma.
    Zhao H; Wang L; Wang S; Chen X; Liang M; Zhang X; Wang J; Xu X
    J Transl Med; 2021 Jul; 19(1):295. PubMed ID: 34238315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
    Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nobiletin inhibits invasion via inhibiting AKT/GSK3β/β-catenin signaling pathway in Slug-expressing glioma cells.
    Zhang X; Zheng K; Li C; Zhao Y; Li H; Liu X; Long Y; Yao J
    Oncol Rep; 2017 May; 37(5):2847-2856. PubMed ID: 28339056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitor of β-catenin and TCF (ICAT) promotes cervical cancer growth and metastasis by disrupting E-cadherin/β-catenin complex.
    Jiang Y; Ren W; Wang W; Xia J; Gou L; Liu M; Wan Q; Zhou L; Weng Y; He T; Zhang Y
    Oncol Rep; 2017 Nov; 38(5):2597-2606. PubMed ID: 29048651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.
    Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ
    J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid binding protein 4 promotes epithelial-mesenchymal transition in cervical squamous cell carcinoma through AKT/GSK3β/Snail signaling pathway.
    Jin J; Zhang Z; Zhang S; Chen X; Chen Z; Hu P; Wang J; Xie C
    Mol Cell Endocrinol; 2018 Feb; 461():155-164. PubMed ID: 28893569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α-Actinin-4 Promotes the Progression of Prostate Cancer Through the Akt/GSK-3β/β-Catenin Signaling Pathway.
    Park S; Kang M; Kim S; An HT; Gettemans J; Ko J
    Front Cell Dev Biol; 2020; 8():588544. PubMed ID: 33363146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquisition of epithelial-mesenchymal transition phenotype and cancer stem cell-like properties in cisplatin-resistant lung cancer cells through AKT/β-catenin/Snail signaling pathway.
    Wang H; Zhang G; Zhang H; Zhang F; Zhou B; Ning F; Wang HS; Cai SH; Du J
    Eur J Pharmacol; 2014 Jan; 723():156-66. PubMed ID: 24333218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
    Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SALL4 promotes the tumorigenicity of cervical cancer cells through activation of the Wnt/β-catenin pathway via CTNNB1.
    Chen M; Li L; Zheng PS
    Cancer Sci; 2019 Sep; 110(9):2794-2805. PubMed ID: 31336010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse double minute 2 (MDM2) upregulates Snail expression and induces epithelial-to-mesenchymal transition in breast cancer cells in vitro and in vivo.
    Lu X; Yan C; Huang Y; Shi D; Fu Z; Qiu J; Yin Y
    Oncotarget; 2016 Jun; 7(24):37177-37191. PubMed ID: 27184007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK/Elk-1/Snail and AKT/GSK3β/β-catenin pathways.
    Zhao J; Ou B; Han D; Wang P; Zong Y; Zhu C; Liu D; Zheng M; Sun J; Feng H; Lu A
    Mol Cancer; 2017 Mar; 16(1):70. PubMed ID: 28356111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.